Bradykinin B1 Receptor
Bradykinin B1 Receptor market is segmented by players, region (country), by Type and by Applicati ... Read More
Global Nuclear Receptor ROR-Gamma Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nuclear Receptor ROR-Gamma Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Receptor ROR-Gamma Market Perspective (2017-2028)
2.2 Nuclear Receptor ROR-Gamma Growth Trends by Region
2.2.1 Nuclear Receptor ROR-Gamma Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nuclear Receptor ROR-Gamma Historic Market Size by Region (2017-2022)
2.2.3 Nuclear Receptor ROR-Gamma Forecasted Market Size by Region (2023-2028)
2.3 Nuclear Receptor ROR-Gamma Market Dynamics
2.3.1 Nuclear Receptor ROR-Gamma Industry Trends
2.3.2 Nuclear Receptor ROR-Gamma Market Drivers
2.3.3 Nuclear Receptor ROR-Gamma Market Challenges
2.3.4 Nuclear Receptor ROR-Gamma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue
3.1.1 Global Top Nuclear Receptor ROR-Gamma Players by Revenue (2017-2022)
3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Players (2017-2022)
3.2 Global Nuclear Receptor ROR-Gamma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue
3.4 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio
3.4.1 Global Nuclear Receptor ROR-Gamma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Receptor ROR-Gamma Revenue in 2021
3.5 Nuclear Receptor ROR-Gamma Key Players Head office and Area Served
3.6 Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
3.7 Date of Enter into Nuclear Receptor ROR-Gamma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Receptor ROR-Gamma Breakdown Data by Type
4.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Type (2017-2022)
4.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2023-2028)
5 Nuclear Receptor ROR-Gamma Breakdown Data by Application
5.1 Global Nuclear Receptor ROR-Gamma Historic Market Size by Application (2017-2022)
5.2 Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nuclear Receptor ROR-Gamma Market Size (2017-2028)
6.2 North America Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
6.3 North America Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nuclear Receptor ROR-Gamma Market Size (2017-2028)
7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size (2017-2028)
8.2 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
8.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nuclear Receptor ROR-Gamma Market Size (2017-2028)
9.2 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
9.3 Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size (2017-2028)
10.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
10.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 4SC AG
11.1.1 4SC AG Company Detail
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Nuclear Receptor ROR-Gamma Introduction
11.1.4 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.1.5 4SC AG Recent Development
11.2 Advinus Therapeutics Ltd.
11.2.1 Advinus Therapeutics Ltd. Company Detail
11.2.2 Advinus Therapeutics Ltd. Business Overview
11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Introduction
11.2.4 Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.2.5 Advinus Therapeutics Ltd. Recent Development
11.3 Arrien Pharmaceuticals, LLC
11.3.1 Arrien Pharmaceuticals, LLC Company Detail
11.3.2 Arrien Pharmaceuticals, LLC Business Overview
11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Introduction
11.3.4 Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.3.5 Arrien Pharmaceuticals, LLC Recent Development
11.4 Aurigene Discovery Technologies Limited
11.4.1 Aurigene Discovery Technologies Limited Company Detail
11.4.2 Aurigene Discovery Technologies Limited Business Overview
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Introduction
11.4.4 Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.4.5 Aurigene Discovery Technologies Limited Recent Development
11.5 Biogen, Inc.
11.5.1 Biogen, Inc. Company Detail
11.5.2 Biogen, Inc. Business Overview
11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Introduction
11.5.4 Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.5.5 Biogen, Inc. Recent Development
11.6 Brickell Biotech, Inc.
11.6.1 Brickell Biotech, Inc. Company Detail
11.6.2 Brickell Biotech, Inc. Business Overview
11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.6.4 Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.6.5 Brickell Biotech, Inc. Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Detail
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Detail
11.8.2 Celgene Corporation Business Overview
11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Introduction
11.8.4 Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.8.5 Celgene Corporation Recent Development
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Detail
11.9.2 Genentech, Inc. Business Overview
11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Introduction
11.9.4 Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.9.5 Genentech, Inc. Recent Development
11.10 Genfit SA
11.10.1 Genfit SA Company Detail
11.10.2 Genfit SA Business Overview
11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Introduction
11.10.4 Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.10.5 Genfit SA Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Detail
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.11.5 GlaxoSmithKline Plc Recent Development
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Detail
11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Introduction
11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
11.13 Karo Bio AB
11.13.1 Karo Bio AB Company Detail
11.13.2 Karo Bio AB Business Overview
11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Introduction
11.13.4 Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.13.5 Karo Bio AB Recent Development
11.14 Lead Pharma Holding B.V.
11.14.1 Lead Pharma Holding B.V. Company Detail
11.14.2 Lead Pharma Holding B.V. Business Overview
11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Introduction
11.14.4 Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.14.5 Lead Pharma Holding B.V. Recent Development
11.15 Nuevolution AB
11.15.1 Nuevolution AB Company Detail
11.15.2 Nuevolution AB Business Overview
11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Introduction
11.15.4 Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.15.5 Nuevolution AB Recent Development
11.16 Phenex Pharmaceuticals AG
11.16.1 Phenex Pharmaceuticals AG Company Detail
11.16.2 Phenex Pharmaceuticals AG Business Overview
11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Introduction
11.16.4 Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.16.5 Phenex Pharmaceuticals AG Recent Development
11.17 Reata Pharmaceuticals, Inc.
11.17.1 Reata Pharmaceuticals, Inc. Company Detail
11.17.2 Reata Pharmaceuticals, Inc. Business Overview
11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.17.4 Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.17.5 Reata Pharmaceuticals, Inc. Recent Development
11.18 Teijin Pharma Limited
11.18.1 Teijin Pharma Limited Company Detail
11.18.2 Teijin Pharma Limited Business Overview
11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Introduction
11.18.4 Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.18.5 Teijin Pharma Limited Recent Development
11.19 Visionary Pharmaceuticals, Inc.
11.19.1 Visionary Pharmaceuticals, Inc. Company Detail
11.19.2 Visionary Pharmaceuticals, Inc. Business Overview
11.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.19.4 Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.19.5 Visionary Pharmaceuticals, Inc. Recent Development
11.20 Vitae Pharmaceuticals, Inc.
11.20.1 Vitae Pharmaceuticals, Inc. Company Detail
11.20.2 Vitae Pharmaceuticals, Inc. Business Overview
11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Introduction
11.20.4 Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022)
11.20.5 Vitae Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of VPR-66
Table 3. Key Players of INV-17
Table 4. Key Players of GSK-2981278
Table 5. Key Players of BBI-6000
Table 6. Key Players of Others
Table 7. Global Nuclear Receptor ROR-Gamma Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nuclear Receptor ROR-Gamma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Nuclear Receptor ROR-Gamma Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Nuclear Receptor ROR-Gamma Market Share by Region (2017-2022)
Table 11. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Nuclear Receptor ROR-Gamma Market Share by Region (2023-2028)
Table 13. Nuclear Receptor ROR-Gamma Market Trends
Table 14. Nuclear Receptor ROR-Gamma Market Drivers
Table 15. Nuclear Receptor ROR-Gamma Market Challenges
Table 16. Nuclear Receptor ROR-Gamma Market Restraints
Table 17. Global Nuclear Receptor ROR-Gamma Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Nuclear Receptor ROR-Gamma Market Share by Players (2017-2022)
Table 19. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2021)
Table 20. Ranking of Global Top Nuclear Receptor ROR-Gamma Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Nuclear Receptor ROR-Gamma Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nuclear Receptor ROR-Gamma Product Solution and Service
Table 24. Date of Enter into Nuclear Receptor ROR-Gamma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2017-2022)
Table 28. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2023-2028)
Table 30. Global Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2017-2022)
Table 32. Global Nuclear Receptor ROR-Gamma Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2023-2028)
Table 34. North America Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2023-2028) & (US$ Million)
Table 44. 4SC AG Company Detail
Table 45. 4SC AG Business Overview
Table 46. 4SC AG Nuclear Receptor ROR-Gamma Product
Table 47. 4SC AG Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 48. 4SC AG Recent Development
Table 49. Advinus Therapeutics Ltd. Company Detail
Table 50. Advinus Therapeutics Ltd. Business Overview
Table 51. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product
Table 52. Advinus Therapeutics Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 53. Advinus Therapeutics Ltd. Recent Development
Table 54. Arrien Pharmaceuticals, LLC Company Detail
Table 55. Arrien Pharmaceuticals, LLC Business Overview
Table 56. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product
Table 57. Arrien Pharmaceuticals, LLC Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 58. Arrien Pharmaceuticals, LLC Recent Development
Table 59. Aurigene Discovery Technologies Limited Company Detail
Table 60. Aurigene Discovery Technologies Limited Business Overview
Table 61. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product
Table 62. Aurigene Discovery Technologies Limited Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 63. Aurigene Discovery Technologies Limited Recent Development
Table 64. Biogen, Inc. Company Detail
Table 65. Biogen, Inc. Business Overview
Table 66. Biogen, Inc. Nuclear Receptor ROR-Gamma Product
Table 67. Biogen, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 68. Biogen, Inc. Recent Development
Table 69. Brickell Biotech, Inc. Company Detail
Table 70. Brickell Biotech, Inc. Business Overview
Table 71. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product
Table 72. Brickell Biotech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 73. Brickell Biotech, Inc. Recent Development
Table 74. Bristol-Myers Squibb Company Company Detail
Table 75. Bristol-Myers Squibb Company Business Overview
Table 76. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product
Table 77. Bristol-Myers Squibb Company Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 78. Bristol-Myers Squibb Company Recent Development
Table 79. Celgene Corporation Company Detail
Table 80. Celgene Corporation Business Overview
Table 81. Celgene Corporation Nuclear Receptor ROR-Gamma Product
Table 82. Celgene Corporation Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 83. Celgene Corporation Recent Development
Table 84. Genentech, Inc. Company Detail
Table 85. Genentech, Inc. Business Overview
Table 86. Genentech, Inc. Nuclear Receptor ROR-Gamma Product
Table 87. Genentech, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 88. Genentech, Inc. Recent Development
Table 89. Genfit SA Company Detail
Table 90. Genfit SA Business Overview
Table 91. Genfit SA Nuclear Receptor ROR-Gamma Product
Table 92. Genfit SA Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 93. Genfit SA Recent Development
Table 94. GlaxoSmithKline Plc Company Detail
Table 95. GlaxoSmithKline Plc Business Overview
Table 96. GlaxoSmithKline Plc Nuclear Receptor ROR-GammaProduct
Table 97. GlaxoSmithKline Plc Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 98. GlaxoSmithKline Plc Recent Development
Table 99. Hanmi Pharmaceuticals, Co. Ltd. Company Detail
Table 100. Hanmi Pharmaceuticals, Co. Ltd. Business Overview
Table 101. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-GammaProduct
Table 102. Hanmi Pharmaceuticals, Co. Ltd. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 103. Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table 104. Karo Bio AB Company Detail
Table 105. Karo Bio AB Business Overview
Table 106. Karo Bio AB Nuclear Receptor ROR-GammaProduct
Table 107. Karo Bio AB Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 108. Karo Bio AB Recent Development
Table 109. Lead Pharma Holding B.V. Company Detail
Table 110. Lead Pharma Holding B.V. Business Overview
Table 111. Lead Pharma Holding B.V. Nuclear Receptor ROR-GammaProduct
Table 112. Lead Pharma Holding B.V. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 113. Lead Pharma Holding B.V. Recent Development
Table 114. Nuevolution AB Company Detail
Table 115. Nuevolution AB Business Overview
Table 116. Nuevolution AB Nuclear Receptor ROR-GammaProduct
Table 117. Nuevolution AB Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 118. Nuevolution AB Recent Development
Table 119. Phenex Pharmaceuticals AG Company Detail
Table 120. Phenex Pharmaceuticals AG Business Overview
Table 121. Phenex Pharmaceuticals AG Nuclear Receptor ROR-GammaProduct
Table 122. Phenex Pharmaceuticals AG Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 123. Phenex Pharmaceuticals AG Recent Development
Table 124. Reata Pharmaceuticals, Inc. Company Detail
Table 125. Reata Pharmaceuticals, Inc. Business Overview
Table 126. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-GammaProduct
Table 127. Reata Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 128. Reata Pharmaceuticals, Inc. Recent Development
Table 129. Teijin Pharma Limited Company Detail
Table 130. Teijin Pharma Limited Business Overview
Table 131. Teijin Pharma Limited Nuclear Receptor ROR-GammaProduct
Table 132. Teijin Pharma Limited Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 133. Teijin Pharma Limited Recent Development
Table 134. Visionary Pharmaceuticals, Inc. Company Detail
Table 135. Visionary Pharmaceuticals, Inc. Business Overview
Table 136. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-GammaProduct
Table 137. Visionary Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 138. Visionary Pharmaceuticals, Inc. Recent Development
Table 139. Vitae Pharmaceuticals, Inc. Company Detail
Table 140. Vitae Pharmaceuticals, Inc. Business Overview
Table 141. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-GammaProduct
Table 142. Vitae Pharmaceuticals, Inc. Revenue in Nuclear Receptor ROR-Gamma Business (2017-2022) & (US$ Million)
Table 143. Vitae Pharmaceuticals, Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Receptor ROR-Gamma Market Share by Type: 2021 VS 2028
Figure 2. VPR-66 Features
Figure 3. INV-17 Features
Figure 4. GSK-2981278 Features
Figure 5. BBI-6000 Features
Figure 6. Others Features
Figure 7. Global Nuclear Receptor ROR-Gamma Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 12. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Nuclear Receptor ROR-Gamma Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nuclear Receptor ROR-Gamma Market Share by Region: 2021 VS 2028
Figure 15. Global Nuclear Receptor ROR-Gamma Market Share by Players in 2021
Figure 16. Global Top Nuclear Receptor ROR-Gamma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR-Gamma as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Nuclear Receptor ROR-Gamma Revenue in 2021
Figure 18. North America Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Nuclear Receptor ROR-Gamma Market Share by Country (2017-2028)
Figure 20. United States Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2017-2028)
Figure 24. Germany Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Receptor ROR-Gamma Market Share by Region (2017-2028)
Figure 32. China Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Nuclear Receptor ROR-Gamma Market Share by Country (2017-2028)
Figure 40. Mexico Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2017-2028)
Figure 44. Turkey Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Nuclear Receptor ROR-Gamma Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. 4SC AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 47. Advinus Therapeutics Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 48. Arrien Pharmaceuticals, LLC Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 49. Aurigene Discovery Technologies Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 50. Biogen, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 51. Brickell Biotech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 52. Bristol-Myers Squibb Company Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 53. Celgene Corporation Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 54. Genentech, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 55. Genfit SA Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 56. GlaxoSmithKline Plc Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 57. Hanmi Pharmaceuticals, Co. Ltd. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 58. Karo Bio AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 59. Lead Pharma Holding B.V. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 60. Nuevolution AB Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 61. Phenex Pharmaceuticals AG Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 62. Reata Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 63. Teijin Pharma Limited Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 64. Visionary Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 65. Vitae Pharmaceuticals, Inc. Revenue Growth Rate in Nuclear Receptor ROR-Gamma Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
4SC AG Advinus Therapeutics Ltd. Arrien Pharmaceuticals, LLC Aurigene Discovery Technologies Limited Biogen, Inc. Brickell Biotech, Inc. Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. Genfit SA GlaxoSmithKline Plc Hanmi Pharmaceuticals, Co. Ltd. Karo Bio AB Lead Pharma Holding B.V. Nuevolution AB Phenex Pharmaceuticals AG Reata Pharmaceuticals, Inc. Teijin Pharma Limited Visionary Pharmaceuticals, Inc. Vitae Pharmaceuticals, Inc.